Chambal Fertilisers share price is drawing renewed investor attention as the company diversifies beyond its core urea business into Technical Ammonium Nitrate (TAN), specialty nutrients, and biologicals while maintaining one of the strongest balance sheets in the fertiliser sector. Despite planned maintenance shutdowns and near-term cash flow pressures linked to expansion capex, Chambal’s return ratios and valuation continue to stand out among sector peers.
This article breaks down the company’s latest fundamentals, technical setup, key support and resistance zones, and what these developments could mean for long-term investors tracking Chambal Fertilisers share price.
Chambal Fertilisers maintained a strong core urea business with 3.4 million tonnes of sales in FY26, while commissioning its new Technical Ammonium Nitrate (TAN) project in April 2026 to diversify earnings. The company has a strong balance sheet (Debt-to-Equity of 0.10, ROCE of 25.5%) and trades at an attractive valuation (P/E of 9.1x). On the charts, the stock trades above its 200-week moving average support of ₹421 but remains below the 50-week (₹466) and 100-week (₹505) moving averages, with a weekly close above ₹466 needed to confirm a bullish breakout.
Key Takeaways
Fundamental Analysis of Chambal Fertilisers Share Price
1. Core Urea Business Remains Strong Despite Planned Shutdowns
Chambal maintained its leadership in India’s urea industry despite planned maintenance shutdowns at the Gadepan plants.
- Urea sales remained healthy at 3.4 million tonnes in FY26 (vs 3.47 million tonnes in FY25).
- Production was temporarily impacted by scheduled shutdowns rather than demand weakness.
- With Gadepan-I restarting, production volumes are expected to normalise in FY27.
Investment View: The core urea business remains structurally strong, with high plant utilisation expected going forward.
2. Government’s Push for Domestic Urea Manufacturing Is a Major Tailwind
The Government continues to prioritise reducing India’s dependence on imported urea by encouraging domestic production. Key positives include:
- New National Investment Policy for Urea
- New domestic urea capacity being added
- Strong subsidy support continuing
For Chambal, one of India’s largest private urea producers, this provides stable demand, high utilisation, and long-term earnings visibility.
3. Diversification Through TAN Is a Major Earnings Catalyst
FY26 marked the commissioning of the Technical Ammonium Nitrate (TAN) project. Management indicated:
- TAN commissioned in April 2026
- Initial utilisation expected at 75–80%
- Capacity around 700 tonnes/day
TAN caters to Mining, Infrastructure, Construction, and the Explosives industry. Unlike urea, TAN is non-subsidised, offers better pricing power, and delivers higher margins significantly diversifying Chambal’s earnings base.
4. Nitric Acid Value Chain Creates Higher Value Addition
The company has entered an integrated industrial chemicals business, following the value chain:
Instead of selling only ammonia, Chambal now converts it into higher-value industrial products. This increases value addition, EBITDA margins, and return on capital employed over time.
5. Specialty Nutrients and Biological Business Emerging as New Growth Engine
Management continues reducing dependence on traditional urea.
FY26 achievements:
- 17 new crop-protection products launched
- Biological revenue increased 57%
- Biological volumes increased 30%
FY27 pipeline:
- 14 new crop-protection products
- 1 specialty nutrient
The biological segment benefits from sustainable farming, precision agriculture, and higher margins than commodity fertilizers.
6. Strong Strategic Partnerships Strengthen Competitive Position
Chambal continues strengthening its product portfolio through global collaborations, including:
- Nutrien
- Corteva
- Syngenta
- TERI (Research Centre)
- IMACID JV
These partnerships bring better technology, product innovation, raw material security, and expansion in specialty fertilizers reducing business concentration risk.
7. Raw Material Inflation Remains the Biggest Near-Term Risk
India remains highly dependent on imported LNG, Ammonia, and Sulphur. FY26 witnessed a sharp rise in ammonia prices, elevated sulphur prices, and continued LNG volatility. Although Chambal implemented cost controls, sustained input inflation may pressure margins if fertilizer prices or subsidies do not adjust accordingly.
8. Balance Sheet Remains One of the Strongest in the Sector
Financial strength remains a key competitive advantage.
| Metric | Value |
|---|---|
| Debt-to-Equity | 0.10 |
| Interest Coverage | 380x |
| ROCE | 25.5% |
| ROE | 20.4% |
| Dividend Yield | 2.47% |
The company has ample financial flexibility to fund future expansion without stressing the balance sheet.
9. Valuation Appears Attractive Relative to Fundamentals
Current valuation metrics suggest Chambal trades below many sector peers.
| Metric | Value |
|---|---|
| P/E | 9.1x |
| EV/EBITDA | 6.3x |
| PEG Ratio | 0.37 |
| ROCE | 25.5% |
Despite industry-leading profitability, the new TAN business, and strong return ratios, the stock trades at a discount to many fertilizer peers, offering potential re-rating if execution remains strong.
10. Cash Flow and Working Capital Need Close Monitoring
This is the primary watchpoint for the company.
Concerns include:
- Operating Cash Flow declined sharply in FY26
- Free Cash Flow turned negative due to higher capital expenditure
- Debtor days increased from 8 to 36 days
- Subsidy receivables rose significantly during FY26 before collections improved
Working capital requirements increased as the company invested in growth projects and carried higher receivables. However, much of the cash flow pressure appears linked to the commissioning of the TAN project, expansion capex, and the timing of government subsidy receipts. If TAN ramps up successfully and subsidy collections normalise, operating cash flow should improve over the medium term.
Technical Analysis of Chambal Fertilisers Share Price
Long-Term Trend – Bullish but in Consolidation
The stock remains in a long-term uptrend despite correcting nearly 35–40% from its peak around ₹720. It has been consolidating for several months, indicating profit booking rather than a breakdown.
Moving Average Analysis
| Moving Average | Level | View |
|---|---|---|
| 50 WMA | ₹466 | Immediate Resistance |
| 100 WMA | ₹505 | Strong Resistance |
| 200 WMA | ₹421 | Major Long-Term Support |
The stock is trading above the 200-week moving average, suggesting the long-term structure is still intact. It remains below the 50-week and 100-week moving averages, indicating medium-term weakness.
Chart Pattern
The stock has formed a base around ₹420–445 after a prolonged correction. Price is attempting to move out of this consolidation, indicating accumulation by buyers. A weekly close above ₹466 would improve the probability of a bullish breakout.
Volume Analysis
Volumes have moderated during the consolidation, suggesting selling pressure has reduced. A breakout above ₹466 should ideally be accompanied by higher-than-average volume to confirm institutional buying.
Momentum Outlook
Momentum is improving as the stock rebounds from the 200-week moving average. However, it needs to sustain above ₹466 to confirm a stronger recovery. Until then, the stock is in a neutral-to-positive phase.
Support & Resistance Levels
| Level Type | Price Zone | Significance |
|---|---|---|
| Immediate Support | ₹435–440 | Current consolidation zone; buyers have repeatedly defended this area |
| Strong Support | ₹421 | 200-week Moving Average; a decisive close below this level would weaken the long-term trend |
| Major Support | ₹409 | Historical demand zone and previous swing support; likely to attract long-term buyers if tested |
| Immediate Resistance | ₹466 | 50-week Moving Average; first hurdle for a sustained recovery |
| Strong Resistance | ₹492–505 | Previous swing highs and the 100-week Moving Average; a breakout above this zone would confirm a medium-term trend reversal |
Bullish & Bearish Scenarios
Bullish Scenario:
- Breakout Trigger: Weekly close above ₹466
- Target 1: ₹492
- Target 2: ₹505
- Target 3: ₹560–580 (if momentum strengthens)
Bearish Scenario: A weekly close below ₹421 could lead to further downside towards ₹409 and then ₹380.
Risk-Reward: The current zone offers a reasonable risk-reward for long-term investors because the stock is trading close to major long-term support. Confirmation of strength requires a move above ₹466.
Risks & Growth Drivers
Growth Drivers:
- TAN project commissioning in April 2026, diversifying earnings beyond subsidised urea into non-subsidised, higher-margin products
- Government’s National Investment Policy for Urea and continued subsidy support providing long-term demand visibility
- Strong momentum in the biological business, with revenue up 57% and volumes up 30% in FY26
- Global strategic partnerships (Nutrien, Corteva, Syngenta, TERI, IMACID JV) strengthening technology and product innovation
- Industry-leading return ratios (ROCE of 25.5%, ROE of 20.4%) alongside an attractive valuation (P/E of 9.1x)
Risks Noted in the Data:
- Raw material inflation remains the biggest near-term risk, given India’s dependence on imported LNG, Ammonia and Sulphur
- Sharp rise in ammonia prices, elevated sulphur prices, and continued LNG volatility in FY26
- Operating cash flow declined sharply in FY26, and free cash flow turned negative due to higher capital expenditure
- Debtor days increased from 8 to 36 days, with subsidy receivables rising significantly before collections improved
- Sustained input inflation may pressure margins if fertilizer prices or subsidies do not adjust accordingly
Analyst View
Based on the fundamental data provided, Chambal Fertilisers presents a case of a structurally strong core urea business being layered with new, higher-margin growth engines TAN, the nitric acid value chain, and specialty nutrients and biologicals. The company’s balance sheet strength (Debt-to-Equity of 0.10, ROCE of 25.5%) and attractive valuation (P/E of 9.1x, PEG of 0.37) stand out relative to sector peers, according to the data reviewed. The main watchpoint remains the FY26 cash flow pressure, which appears linked to TAN commissioning, expansion capex, and subsidy receivable timing rather than a deterioration in the core business.
From a technical standpoint, the stock is in a consolidation phase within a longer-term uptrend holding above its 200-week moving average support but needing a decisive move above ₹466 to confirm a stronger medium-term recovery.